SUN PHARMA GLOBAL FDA Approval ANDA 202423

ANDA 202423

SUN PHARMA GLOBAL

FDA Drug Application

Application #202423

Application Sponsors

ANDA 202423SUN PHARMA GLOBAL

Marketing Status

None (Tentative Approval)001
None (Tentative Approval)002
None (Tentative Approval)003

Application Products

001TABLET; ORAL25MG0SITAGLIPTIN PHOSPHATESITAGLIPTIN PHOSPHATE
002TABLET; ORAL50MG0SITAGLIPTIN PHOSPHATESITAGLIPTIN PHOSPHATE
003TABLET; ORAL100MG0SITAGLIPTIN PHOSPHATESITAGLIPTIN PHOSPHATE

FDA Submissions

UNKNOWN; ORIG1TA2013-04-11

Submissions Property Types

ORIG1Null17

CDER Filings

SUN PHARMA GLOBAL
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 202423
            [companyName] => SUN PHARMA GLOBAL
            [docInserts] => ["",""]
            [products] => [{"drugName":"SITAGLIPTIN PHOSPHATE","activeIngredients":"SITAGLIPTIN PHOSPHATE","strength":"25MG","dosageForm":"TABLET; ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"SITAGLIPTIN PHOSPHATE","activeIngredients":"SITAGLIPTIN PHOSPHATE","strength":"50MG","dosageForm":"TABLET; ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"SITAGLIPTIN PHOSPHATE","activeIngredients":"SITAGLIPTIN PHOSPHATE","strength":"100MG","dosageForm":"TABLET; ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"04\/11\/2013","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2013-04-11
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.